MiRNA-based Therapeutic Strategy in Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|39|6011-6018

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.39, 2018-02, pp. : 6011-6018

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MiRNA-based Therapeutics for Lung Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5989-5996

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects of miRNA-Based Therapy for Pancreatic Cancer

By  

Current Drug Targets, Vol. 14, Iss. 10, 2013-09 ,pp. : 1101-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2040-2050

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Towards MiRNA Based Therapeutics for Lung Cancer

By  

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5971-5972

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Novel miRNA-based Vaccines and Antivirals against Enterovirus 71

By  

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6694-6700

Bentham Science Publishers

Access to resources Recommend Favorite